Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

July 17, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Is the frequent prescription of PPI medicines a boon or a bane?

SADS-CoV, a new type of coronavirus can infect humans

A Paradigm unleashes to target Ovarian Carcinoma

Is the frequent prescription of PPI medicines a boon or a bane?
  • BiotechToday
  • World

Is the frequent prescription of PPI medicines a boon or a bane?

bioxone October 18, 2020October 18, 2020

Husna, Amity University Kolkata

Proton pump inhibitors (PPIs) are a class of medicines that work on the cells which are lining the stomach, reducing the production of acid in our stomach. They can treat heartburn and gastric acid reflux by irreversibly binding with the Na+ H+ ATPase located on the surface of gastric parietal cells.
PPIs include pantoprazole, omeprazole, rabeprazole, lansoprazole and various other brands. 

These medicines can be used safely for up to 14 days daily with not over 3 such treatment courses in a year and their short-term use is well tolerated. However, the concern is that if such medications are prescribed more frequently and consumed excessively then they can cause tremendous side- effects. A study found that PPI was used by 66.6% of the patients and most of the physicians were found to be prescribing such medications for the long term by ignoring their adverse effects which are mentioned below:

  1. Magnesium deficiency: The US FDA warned in 2011 regarding the danger of taking PPIs excessively which leads to a deficiency of magnesium within the body known as hypomagnesemia. Low amounts of magnesium can cause muscle stiffness, spasm and seizures.
  2. Bone fracture risk: When patients with type-2 diabetes use PPI frequently then, there’s a 40% high risk of hip fractures in them.
  3. Vitamin B-12 deficiency: In a case study it was observed that people who consumed more than one PPI pills every day for up to 2 years suffered from Vitamin B-12 deficiency which can cause major health issues like anaemia, dementia and neurocognitive damage.
  4. Persistent Diarrhoea: The gut composition gets altered if we take a medication excessively and in higher doses which leads to the development of certain risky infections like Clostridium difficle infection. This is associated with high morbidity and may even cause death. 
  5. Diabetes: A recent study on gut found that active PPI users have 24% greater risk of developing diabetes.
  6. Renal dysfunction: Excessive use of PPI for long-term causes of’ kidney failure.

Therefore, all these studies on PPI highlight that the need of the hour is to reduce our practice of consuming PPI which has become a commonly purchased over-the-counter drug. Clinicians should prescribe PPI to the patients only when necessary and they can advise the patients to take a specified amount of dose rather than over-consumption.

Also read: The Critical role of UGP2 – Pancreatic Ductal Adenocarcinoma Treatment

Source:

https://medicaldialogues.in/medicine/perspective/prescribing-proton-pump-inhibitors-need-paradigm-shift-in-the-practice-70573

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Anaemia clinical research clinician Diabetes diarrhoea doses FDA fracture gastric acid reflux heartburn hypomagnesemia infections lansoprazole medications morbidity neuro-cognitive damage omeprazole over-the-counter drug pantoprazole patients pills PPIs prescriptions proton pump inhibitors rabeprazole renal dysfunction side-effects stomach treatment

4 thoughts on “Is the frequent prescription of PPI medicines a boon or a bane?”

  1. Swetalika Das says:
    October 19, 2020 at 4:11 pm

    Very well written ❤️

    Reply
    1. H says:
      October 19, 2020 at 7:00 pm

      Great work 👌

      Reply
  2. Swetalika Das says:
    October 19, 2020 at 4:12 pm

    So informative ❤️ Keep writing 👍🏻

    Reply
  3. Farah says:
    October 20, 2020 at 5:07 pm

    As usual, excellent article dear Husna☺ indeed a very crucial information & awareness for all physicians.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

A Paradigm unleashes to target Ovarian Carcinoma

bioxone October 19, 2020

Chitra Roy, University of Calcutta High-Grade Serous Ovarian Carcinoma (HGSOC) is one of the most common and deadliest types of ovarian cancer. This gynaecological malignancy is a type of tumour which arises from the ovary, fallopian tube, or peritoneum. The tumour microenvironment is very complex and 40% of this tumour mass contains Macrophages. Macrophages originate […]

Ovarian

Related Post

  • BiotechToday
  • World

Application of Embryonic stem cells in drug discovery

bioxone August 29, 2021August 29, 2021

Ananya Ghosal, MAKAUT (WB) Teratogenicity is tested for use in the patient with childbearing potential before marketing. Animal-free in-vitro models allow fast selection of lead compounds which further contribute to 3R’s principle i.e., Refine, Replace and reduce by smoothly selecting the compounds that are submitted for the regulatory studies in animals. Disorganized 3D structures and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Nano catalytic tumour therapy by single-atom catalysts

bioxone January 26, 2021January 26, 2021

Rohit Bhattacharjee, Amity University, Kolkata Recently, single‐atom catalysts (SACs) are receiving increasing attention in varied chemical process fields, and meantime, rising nano catalytic drugs provide a unique tumor therapy modality while not victimizing harmful chemo drugs. The distinct properties of SACs, like exactly situated metal centers, identical coordination setting, tailorable composition and structure, and versatile […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

bioxone October 21, 2020October 21, 2020

Binayak Das, Team Bioxone A study conducted to unravel the potential of immunotherapy for patients affected by the covid-19 virus has announced that treatment with intravenous-immunoglobulin can potentially benefit covid-19 patients that are severely affected. Intravenous immunoglobulin or IVIG is the collection of IgG obtained from the blood serum of a large number of healthy […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy